ARTL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Artelo Biosciences Inc (ARTL) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, financial performance shows significant losses despite improvement, and there are no strong trading or sentiment signals. Additionally, no significant positive catalysts or influential trading activity are present to justify immediate investment.
The MACD histogram is negative and contracting, RSI is neutral at 42.883, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 1.284, with key resistance at 1.437 and support at 1.132. Overall, the technical indicators suggest a bearish trend.
Positive clinical data for ART26.12 and ART27.13, along with favorable regulatory guidance for ART12.11, could support long-term growth if further studies are successful.
The company has shown no revenue growth (0% YoY) and continues to operate at a net loss (-$3.12M in Q3 2025). The stock's bearish technical indicators and lack of significant trading trends from hedge funds or insiders further weigh against the stock.
In Q3 2025, the company reported no revenue growth (0% YoY) and a net loss of -$3.12M, though this reflects a 175.62% YoY improvement. EPS improved to -3.96 (up 88.57% YoY). Despite these improvements, the company remains unprofitable.
No data available for analyst ratings or price target changes.
